Literature DB >> 23255479

Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.

Stefan Van der Mussele1, Kim Bekelaar, Nathalie Le Bastard, Yannick Vermeiren, Jos Saerens, Nore Somers, Peter Mariën, Johan Goeman, Peter P De Deyn, Sebastiaan Engelborghs.   

Abstract

BACKGROUND: Mild cognitive impairment (MCI) is a clinical concept that categorizes subjects who are in an intermediate cognitive state between normal aging and dementia. The aims of this study are to determine the prevalence of significant depressive symptoms in MCI and Alzheimer's disease (AD) patients and to characterize the behavior associated with significant depressive symptoms in MCI and AD patients.
METHODS: A cross-sectional analysis of baseline data from a prospective, longitudinal study on behavioral symptoms of dementia and MCI was performed. The study population consisted of 270 MCI and 402 AD patients. Behavioral assessment was performed by means of Middelheim Frontality Score, Behavioral Pathology in Alzheimer's Disease Rating Scale (Behave-AD) and Cohen-Mansfield Agitation Inventory. The presence of significant depressive symptoms was defined as a Cornell Scale for Depression in Dementia total score >7.
RESULTS: The prevalence of significant depressive symptoms in AD patients (25%) was higher compared with MCI patients (16%) (p = 0.005). Patients with significant depressive symptoms showed an increased severity of frontal lobe symptoms, behavioral symptoms and agitation (Middelheim Frontality Score, Behave-AD and Cohen-Mansfield Agitation Inventory total scores; p < 0.001). Also, most of the individual frontal lobe and behavioral symptoms were more prevalent and severe, resulting in higher Behave-AD global scores. Mild cognitive impairment patients with depressive symptoms showed more severe behavioral symptoms and more severe verbally agitated behavior than AD patients without depressive symptoms (p < 0.001).
CONCLUSIONS: Frontal lobe and behavioral symptoms are more prevalent and severe in MCI and AD patients with significant depressive symptoms as compared with patients without depressive symptoms.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Alzheimer's disease; Cornell Scale; behavioral symptoms; dementia; depression; depressive symptoms; frontal lobe symptoms; mild cognitive impairment

Mesh:

Year:  2012        PMID: 23255479     DOI: 10.1002/gps.3909

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  14 in total

1.  Depression and Alzheimer's Disease Biomarkers Predict Driving Decline.

Authors:  Ganesh M Babulal; Suzie Chen; Monique M Williams; Jean-Francois Trani; Parul Bakhshi; Grace L Chao; Sarah H Stout; Anne M Fagan; Tammie L S Benzinger; David M Holtzman; John C Morris; Catherine M Roe
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

2.  Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis.

Authors:  J K Kuring; J L Mathias; L Ward
Journal:  Neuropsychol Rev       Date:  2018-12-07       Impact factor: 7.444

3.  Cognitive and neuropsychiatric impairments in Alzheimer's disease: current treatment strategies.

Authors:  Anna Borisovskaya; Marcella Pascualy; Soo Borson
Journal:  Curr Psychiatry Rep       Date:  2014-09       Impact factor: 5.285

4.  Depression is Associated with Tau and Not Amyloid Positron Emission Tomography in Cognitively Normal Adults.

Authors:  Ganesh M Babulal; Catherine M Roe; Sarah H Stout; Ganesh Rajasekar; Julie K Wisch; Tammie L S Benzinger; John C Morris; Beau M Ances
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 5.  Behavioral and psychological symptoms in Alzheimer's disease.

Authors:  Xiao-Ling Li; Nan Hu; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Biomed Res Int       Date:  2014-07-15       Impact factor: 3.411

6.  Trajectories of Depressive Symptomatology in Rural Memory Clinic Patients between Baseline Diagnosis and 1-Year Follow-Up.

Authors:  Julie G Kosteniuk; Debra G Morgan; Megan E O'Connell; Andrew Kirk; Margaret Crossley; Norma J Stewart; Chandima P Karunanayake
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-05-03

Review 7.  Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review.

Authors:  Zahra Goodarzi; Bria Mele; Selynne Guo; Heather Hanson; Nathalie Jette; Scott Patten; Tamara Pringsheim; Jayna Holroyd-Leduc
Journal:  BMC Neurol       Date:  2016-11-25       Impact factor: 2.474

8.  Effects of cognitive stimulation therapy Japanese version (CST-J) for people with dementia: a single-blind, controlled clinical trial.

Authors:  Katsuo Yamanaka; Yoshiyuki Kawano; Dai Noguchi; Shutaro Nakaaki; Norio Watanabe; Takashi Amano; Aimee Spector
Journal:  Aging Ment Health       Date:  2013-04-04       Impact factor: 3.658

9.  Prevalence and covariates of elevated depressive symptoms in rural memory clinic patients with mild cognitive impairment or dementia.

Authors:  Julie G Kosteniuk; Debra G Morgan; Megan E O'Connell; Margaret Crossley; Andrew Kirk; Norma J Stewart; Chandima P Karunanayake
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-07-01

Review 10.  Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?

Authors:  Debby Van Dam; Yannick Vermeiren; Alain D Dekker; Petrus J W Naudé; Peter P De Deyn
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.